A patient receives a dose of the COVID-19 vaccine in Nigeria. Credit: i_am_zews / Shutterstock
John,
Global vaccine distribution remains highly unequal, with much of the current supply concentrated in high-income countries. Although there is sufficient supply in some countries like the U.S., vaccination rates have stagnated due to the low acceptance of the population. To better understand vaccine acceptance (willingness to get a COVID-19 vaccine) and hesitancy around the world, researchers from IPA and other research institutions surveyed nearly 45,000 people in late 2020 in 10 low- and middle-income countries (LMICs) as well as the U.S. and Russia.
Without evidence, decision-makers often have to guess the answers to questions like these. IPA works with researchers and our partners to generate evidence on what works, so organizations and governments can make informed decisions.